Biokangtai

Founded in 1992, BioKangtai champions innovation through key scientific research and technology projects, boosting our R&D and industrial capabilities. Follow us for the latest updates! Create better vaccines to benefit human health. 2020 30 202157400 Founded in 1992, BioKangtai has developed into the Dominant Manufacturer of Hepatitis B Vaccine in China, listed in the first tier of “Top 100 Chinese Pharmaceutical Innovation Enterprises”. Over the last 3 decades, BioKangtai has sold more than 1 billion doses of Hepatitis B vaccine, protected more than 300 million people by immunization and saved public health expenditure for the country by more than 160 billion RMB. After decades of investment, the number of launched products and pipelines in BioKangtai ranks first in China vaccine industry, including our Covid-19 inactivated vaccine that has vaccinated for more than 4 million times in China.